Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CROX — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree CROX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CROX — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the Crocs Insider Buying occurred are:

Cognition Therapeutics Insider Buying
Corteva Insider Buying
Staar Surgical Insider Buying
Civista Bancshares Insider Buying
Fluent Insider Buying
United Fire Group Insider Buying
Ekso Bionics Holdings Insider Buying
Xeris Biopharma Holdings Insider Buying
Aprea Therapeutics Insider Buying
Burke Herbert Financial Services Insider Buying

Crocs insider buying image
The table below summarizes the most recent Crocs insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Crocs insider buys are important for investors to follow.
DateInsiderPriceAmount
3-14-2024
Insider Buy		 John B. Replogle
Director		 $126.75
CAGR » 		$249,949.03
1,972 shares
8-18-2023
Insider Buy		 Douglas J. Treff
Director		 $94.61
CAGR » 		$200,016.11
2,114 shares
8-11-2023
Insider Buy		 Anne Mehlman
CFO		 $101.62
CAGR » 		$198,159.00
1,950 shares
8-2-2023
Insider Buy		 Thomas J. Smach
Director		 $105.85
CAGR » 		$1,058,500.00
10,000 shares
8-2-2023
Insider Buy		 Douglas J. Treff
Director		 $103.94
CAGR » 		$200,188.44
1,926 shares
7-28-2023
Insider Buy		 Thomas J. Smach
Director		 $104.53
CAGR » 		$150,000.55
1,435 shares
6-16-2023
Insider Buy		 Thomas J. Smach
Director		 $111.07
CAGR » 		$222,140.00
2,000 shares
3-13-2023
Insider Buy		 Thomas J. Smach
Director		 $113.15
CAGR » 		$339,438.00
3,000 shares
5-25-2022
Insider Buy		 Thomas J. Smach
Director		 $49.99
CAGR » 		$249,950.00
5,000 shares
5-17-2022
Insider Buy		 Ian Bickley
Director		 $58.24
CAGR » 		$291,200.00
5,000 shares
5-9-2022
Insider Buy		 Anne Mehlman
CFO		 $54.91
CAGR » 		$142,766.00
2,600 shares
3-16-2022
Insider Buy		 Ronald Frasch
Director		 $77.02
CAGR » 		$250,309.00
3,250 shares
3-14-2022
Insider Buy		 Charisse Ford Hughes
Director		 $70.62
CAGR » 		$35,310.00
500 shares
3-14-2022
Insider Buy		 Douglas J. Treff
Director		 $67.50
CAGR » 		$199,935.00
2,962 shares
3-7-2022
Insider Buy		 Beth J. Kaplan
Director		 $69.63
CAGR » 		$99,566.61
1,430 shares
3-3-2022
Insider Buy		 Thomas J. Smach
Director		 $78.04
CAGR » 		$390,193.50
5,000 shares
3-3-2022
Insider Buy		 Douglas J. Treff
Director		 $77.96
CAGR » 		$748,389.12
9,600 shares
2-17-2022
Insider Buy		 Douglas J. Treff
Director		 $91.44
CAGR » 		$740,662.38
8,100 shares
2-17-2022
Insider Buy		 Thomas J. Smach
Director		 $86.35
CAGR » 		$1,066,888.94
12,356 shares
3-12-2020
Insider Buy		 Anne Mehlman
CFO		 $18.75
CAGR » 		$58,109.50
3,100 shares
3-6-2020
Insider Buy		 Douglas J. Treff
Director		 $23.73
CAGR » 		$367,279.01
15,475 shares
8-24-2016
Insider Buy		 Carrie W. Teffner
EVP, Chief Financial Officer		 $8.85
CAGR » 		$66,371.25
7,500 shares
3-11-2016
Insider Buy		 Gregg Ribatt
Chief Executive Officer		 $9.25
CAGR » 		$92,470.00
10,000 shares
3-9-2016
Insider Buy		 Ronald Frasch
Director		 $9.22
CAGR » 		$100,494.39
10,895 shares
11-12-2015
Insider Buy		 Andrew Rees
President		 $9.51
CAGR » 		$95,140.00
10,000 shares
11-10-2015
Insider Buy		 Gregg Ribatt
Chief Executive Officer		 $9.98
CAGR » 		$149,700.00
15,000 shares
8-24-2015
Insider Buy		 Andrew Rees
President		 $13.48
CAGR » 		$67,399.00
5,000 shares
8-5-2015
Insider Buy		 Gregg Ribatt
Chief Executive Officer		 $15.23
CAGR » 		$152,284.00
10,000 shares
5-13-2015
Insider Buy		 Gregg Ribatt
Chief Executive Officer		 $14.43
CAGR » 		$144,250.00
10,000 shares
5-14-2015
Insider Buy		 Andrew Rees
President		 $15.24
CAGR » 		$152,352.00
10,000 shares
3-4-2015
Insider Buy		 Andrew Rees
President		 $11.33
CAGR » 		$113,337.00
10,000 shares
3-4-2015
Insider Buy		 Gregg Ribatt
Chief Executive Officer		 $11.47
CAGR » 		$114,727.00
10,000 shares
11-21-2014
Insider Buy		 Ronald Frasch
Director		 $12.88
CAGR » 		$99,795.20
7,750 shares
10-31-2014
Insider Buy		 Andrew Rees
President		 $11.50
CAGR » 		$114,968.00
10,000 shares
10-31-2014
Insider Buy		 Thomas J. Smach
Director		 $11.61
CAGR » 		$116,087.00
10,000 shares
11-3-2014
Insider Buy		 Gregg Ribatt
Director		 $11.55
CAGR » 		$115,498.00
10,000 shares
7-29-2014
Insider Buy		 Andrew Rees
President		 $16.42
CAGR » 		$82,093.00
5,000 shares

Also See: Institutional Holders of CROX
Also See: SEC filings

CROX Performance Since Insider Purchase
Below we present the annualized performance delivered by Crocs stock since 3-14-2024 (the date of the most recent insider purchase). The performance of the investment from the time Crocs insider buying occurred is the ultimate test of whether insiders were right about CROX being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 03/15/2024
End date: 04/29/2024
Start price/share: $128.17
End price/share: $127.69
Dividends collected/share: $0.00
Total return: -0.37%
Annualized Gain: -3.04%
Starting investment: $10,000.00
Ending investment: $9,963.00
Years: 0.12

Crocs Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Crocs insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CROX

Crocs Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.